Thanks for visiting!

This project is now in update mode. Check back regularly to see how things are progressing.

Exploration of Viral Protein for Cancer Research (GD2021)

$5,086
145%
Raised toward our $3,500 Goal
132 Donors
Project has ended
Project ended on April 03, at 11:59 PM EDT
Project Owners

Exploration of Viral Protein for Cancer Research (GD2021)

The Problem

Cancer is unfortunately one of the most alarming and widespread diseases around the world with over one hundred different types, each affecting different body systems. Current treatments are often invasive, nonspecific, and have negative side effects. Beyond health impacts, these treatments are expensive and place financial strains on many families and the healthcare system. Such financial strain is a cause of inequity in healthcare access. Many minoritized populations currently have unequal access to chemotherapy and radiation treatments, consequently causing these groups to be more at risk for developing cancer. The high prevalence, severity, and variation of cancer as well as the inequities that it causes has created a need for efficient treatment with a more targeted approach.

Our Mission

Our research aims to develop more targeted cancer therapy using viral proteins. We are focusing on using a viral protein to inhibit a signaling pathway that often leads to cancer. This pathway has been proven to cause lymphoma. We aim to develop this cancer treatment by inserting the viral protein into lymphoma cells to see if it can cause tumor cell death. Such data can contribute to the cancer therapeutics field by discussing the viral protein’s potential to be used as an affordable lymphoma treatment option. 

About Us 

We are team EVICT, a biomedical based research team in the Gemstone Honors Program at the University of Maryland. Our team consists of ten members with varying majors and research experience, but a common goal of applying viral proteins for therapeutic purposes. Cancer has touched each of our lives in different ways, which is why we are eager to begin our data collection and make a contribution to cancer therapeutics. This team was formed in spring of 2020 and will continue to do research until our thesis defense in April 2023. We are incredibly thankful for our mentor Dr. Yanjin Zhang, as well as our librarian Nedelina Tchangalova, who have been and will continue to be a crucial part of our work.  

Why We Need Your Help 

As an undergraduate research team looking to pursue cancer research in an ongoing pandemic, our university resources are extremely limited. Therefore, we are kindly asking for donations to support our research. Team EVICT would be able to use your donations to purchase much needed lab materials in order for us to begin data collection. These materials include, but are not limited to, retroviral packaging and delivery agents, DNA isolation supplies, chemical solvents, enzyme kits, and cancer cell lines. Donations of any size will make a significant impact on our team’s project and are greatly appreciated. We thank you for your support in advance and we are excited to develop more effective cancer treatment methods to share with you! 

Contact Us and Follow Us

Website: https://srinivsruthi.wixsite.com/team-evict

Email: teamevictumd@gmail.com

Instagram: https://www.instagram.com/team__evict/

Gifts in support of the University of Maryland are accepted and managed by the University of Maryland College Park Foundation, Inc., an affiliated 501(c)(3) organization authorized by the Board of Regents.  Contributions to the University of Maryland are tax-deductible as allowed by law. Please see your tax advisor for details.

Levels
Choose a giving level

$10

$10

Your thoughtful donation will help us purchase important lab reagents needed to culture cancer cells.

$25

$25

Your thoughtful donation will help us purchase needed enzymes to analyze the regulation of the targeted pathway.

$50

$50

Your thoughtful donation will help us purchase DNA isolation and transfection supplies.

$100

$100

Your thoughtful donation will help us purchase lymphoma cell lines needed to test our new cancer therapy treatment.

Our Crowdfunding Groups